Dystonia Daily Practice Prospective, Single-arm, Multicenter Trial to Investigate the Efficacy and Safety of NT 201 and the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Patients With Cervical Dystonia.
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2013
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- 17 Nov 2011 Results will be presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, according to a Merz Pharmaceuticals media release.
- 01 Jun 2010 New trial record